Abstract
Annually, there are approximately 900,000 nosocomial infections in Germany. These infections are often caused by multi-resistant bacteria like MRSA. The spread of these bacteria is fostered by the inappropriate and unnecessary use of antibiotics in the inpatient and outpatient, and also agricultural sector. In order to prevent the spread of multi-resistant organisms, cross-sectoral, concerted actions of health facilities and the community have to be forced. Therefore structures have to be implemented that motivate the players in a health care system to make efforts in infection prevention and patient safety. For countries with a relatively high MRSA rate as it is the case in Germany, it is necessary to have a benchmark with regions or countries like the Netherlands which show a significantly lower MRSA rate. The factors which determine the success of the Dutch prevention strategy have to be clearly evaluated and constructively adopted according to the requirements of the German health care system. The superior aim is to connect the service sectors in the health care system to establish concerted actions in terms of infection prevention. Established regional infection prevention networks show successfully how to overcome sector boundaries as well as internal boundaries, e.g. in hospitals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramson M, Sexton D (1999) Nosocomial methicillin-resistant and methicillin-susceptible staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 20:408–411
Aiken LH, Sloane DM, Bruyneel L, Van den Heede K, Griffiths P, Busse R, Diomidous M, Kinnunen J, Kózka M, Lesaffre E, McHugh MD, Moreno-Casbas MT, Rafferty AM, Schwendlimann R, Scott PA, Tishelman C, van Achterberg T, Sermeus W (2014) Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study. Lancet 383:1824–1830
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (2014) GERMAP 2012. Antibiotika-Resistenz und -Verbrauch. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Antiinfectives Intelligence. Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbh, Rheinbach
Centers for Disease Prevention and Control (2014) Core elements of hospital antibiotic stewardship programs. US Department of Health and Human Services, Atlanta. http://www.cdc.gov/getsmart/healthcare/pdfs/core-elements.pdf. Accessed 7 Jul 2015
Dekker T, van den Broek P (2010) Successful control of MRSA spread in Dutch hospitals. Int J Infect Control 6(1):i1
Engemann J, Carmeli Y, Sogrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kave KS (2003) Adverse clinical and economic outcomes attributable to Methicillin resistance among patients with staphylococcus aureus surgical site infection. Clin Infect Dis 56:592–598
European Centre for Disease Prevention and Control (2014) Antimicrobial resistance surveillance in Europe 2013. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-net). ECDC, Stockholm
Friedrich AW (2009) EUREGIO MRSA-net Twente/Münsterland: search & follow durch euregionale Netzwerkbildung. Gesundheitswesen 71:766–770
Geldner G, Ruoff M, Hoffmann HJ, Georgieff M, Wiedeck H (1999) Eine Kostenanalyse von MRSA-Infektionen auf einer operativen Intensivstation. Anasthesiol Intensivmed Notfallmed Schmerzther 34:409–413
Gesundheitsministerkonferenz (2006) Ergebnisniederschrift der 79. Konferenz der für das Gesundheitswesen zuständigen Ministerinnen, Minister, Senatorinnen und Senatoren der Länder am 29. und 30. Juni in Dessau. https://www.rki.de/DE/Content/Infekt/Krankenhaushygiene/Erreger_ausgewaehlt/MRSA/MRSA_GMK.pdf. Accessed 7 Jul 2015
Greiner W, Rasch A, Köhler D, Salzberger B, Fätkenheier G, Leidig M (2007) Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. Clin Microbiol Infect 13:264–268
Heizmann P, Heizmann WR, Hetzer R (2005) MRSA: Reizmechanismen, Epidemiologie, Risikofaktoren, Prophylaxe, Therapie. Z Herz- Thorax Gefäßchir 19:78–88
Herr CE, Heckrodt TH, Hofmann FA, Schnettler R, Eikmann TF (2003) Additional costs for preventing the spread of Methicilin-resistant staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect Control Hosp Epidemiol 24:673–678
Huebner NO, Huebner C, Kramer A (2009) Ökonomische Aspekte des Hygienemanagements von MRSA. Gesundheitswesen 71(11):771–776
IfSG (2000) Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen. http://www.gesetze-im-internet.de/ifsg/. Accessed 2 Jul 2015
Jevons MP (1961) Celbenin-resistant staphylococci. BMJ 1:124–125
Jurke A, Köck R, Thole S, Hendrix R, Rossen J, Daniels-Haardt, I, Friedrich AW (2013) Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density by a region-wide search and follow-strategy in forty German hospitals of the EUREGIO, 2009 to 2011. Euro Surveill 18(36). pii=20579
Kalenic S, Cookson B, Gallagher R, Popp W et al (2010) Comparison of recommendations in national/regional guidelines for prevention and control of MRSA in thirteen European countries. Int J Infect Control 6(2):i1
Kim T, Oh P, Simor A (2001) The economic impact of methicillin-resistant staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 22:99–104
Polke-Majewski K (2014) Das Wundermittel wirkt nicht mehr. http://www.zeit.de/wissen/gesundheit/2014-11/antibiotika-keime-resistenz-bakterien/komplettansicht. Accessed 1 Jul 2015
Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom JK, Kave KS, Styjewksi ME, Szcech LA, Reller LB, Corey GR, Schulman KA, Fowler VG Jr (2005) Costs and outcomes among hemodialysisdependent patients with methicillin-resistant or methicillin-susceptible staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26:175–183
Resch A, Wilke M, Fink C (2009) The cost of resistance: incremental cost of methicillin-resistant staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ 10:287–297
Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A (1999) The economic impact of staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 5(1):9–17
Salmenlinna S, Lyytikäinen O, Vuopio-Varkila J (2002) Community-acquired methicillin-resistant staphylococcus aureus. Emerg Infect Dis 6(8):602–607
Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH (2006) Morbidity and cost burden of methicillin-resistant staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 10(3):97–103
Statistisches Bundesamt (2014) Kostennachweis der Krankenhäuser. Statistisches Bundesamt, Fachserie 12, Reihe 6.3, 2013. Wiesbaden
Van Rijen MM, Kluytmans JAJW (2009) Costs and benefits of the MRSA search and destroy policy in a Dutch hospital. Eur J Clin Microbiol Infect Dis 28:1245–1252
Walger P, Popp W, Exner M (2013) Stellungnahme der DGKH zu Prävalenz, Letalität und Präventionspotenzial nosokomialer Infektionen in Deutschland 2013. Hyg Med 38(7/8):329–338
Wernitz MH, Keck S, Swidsinski S, Schulz S, Veit SK (2005) Cost analysis of a hospital-wide selective screening programme for methicillin-resistant staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin Microbiol Infect 11:466–471
World Economic Forum (2014) Global risks 2014, 9th edn. World Economic Forum, Switzerland
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Haking, D. (2016). Infection Prevention Networks and the Role of the Boundaryless Hospital. In: Albach, H., Meffert, H., Pinkwart, A., Reichwald, R., von Eiff, W. (eds) Boundaryless Hospital. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49012-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-662-49012-9_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49010-5
Online ISBN: 978-3-662-49012-9
eBook Packages: Business and ManagementBusiness and Management (R0)